Recalls and Safety Alerts: Recall of Ultravist Contrast Agent
Published by Food and Drug Adminstration (FDA): Patient Safety September 30th, 2006 in Patient Safety, Regulatory AffairsIn July, Berlex, Inc. recalled all lots of Ultravist (iopromide) Injection 370mgl/mL, an intravenous contrast agent. These products could contain particulate matter along with crystals. If administered to patients, they could cause vascular thromb…